Showing results (3751-3760 of 10,080) with videos related to
Sort By:
Pageof 1,008
Current Pharmaceutical Design|August 24, 2016
Pharmacological Treatment of Cannabis-Related Disorders: A Narrative ReviewDavid A GorelickCurrent Pharmaceutical Design|August 24, 2016
Targeting Mitochondria in Cardiovascular DiseasesFilomena S G Silva, Rui F Simoes, Renata Couto, et al.Current Pharmaceutical Design|March 19, 2010
In vitro evaluation of potential hepatotoxicity induced by drugsM J Gómez-Lechón, A Lahoz, L Gombau, et al.Current Pharmaceutical Design|March 19, 2010
Nitric oxide and cancer therapy: the emperor has NO clothesJason R Hickok, Douglas D ThomasCurrent Pharmaceutical Design|March 19, 2010
Targeting the L-arginine-nitric oxide pathway for cancer treatmentQingyong Ma, Zheng Wang, Min Zhang, et al.Current Pharmaceutical Design|September 9, 2016
Gut Permeability and Microbiota in Parkinson's Disease: Role of Depression, Tryptophan Catabolites, Oxidative and Nitrosative Stress and Melatonergic PathwaysGeorge Anderson, Moonsang Seo, Michael Berk, et al.Current Pharmaceutical Design|September 9, 2016
The Microbiota and Gut-Brain Axis: Contributions to the Immunopathogenesis of SchizophreniaJavier R Caso, Vicent Balanzá-Martínez, Tomás Palomo, et al.Current Pharmaceutical Design|June 6, 2018
Current Perspectives Regarding Stem Cell-based Therapy for Ischemic StrokeKyeong-Ah Kwak, Ho-Beom Kwon, Joo Won Lee, et al.Current Pharmaceutical Design|March 12, 2009
Chemosensitization and immunosensitization of resistant cancer cells to apoptosis and inhibition of metastasis by the specific NF-kappaB inhibitor DHMEQAlina Katsman, Kazuo Umezawa, Benjamin BonavidaCurrent Pharmaceutical Design|March 12, 2009
The metabolic treatment of patients with coronary artery disease: effects on quality of life and effort anginaL A M César, L H Gowdak, A P MansurPageof 1,008